# Commercial Vehicle Group, Inc.: financial statements, quarterly

CVGI · Nasdaq · CIK 1290900 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cvgi.md) · [Financials](/companies/cvgi/financials.md) · [Filings](/companies/cvgi/filings.md) · [Insiders](/companies/cvgi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvgi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [203](/filings/0001628280-24-045013.md) | [194 d](/filings/0001628280-26-016520.md) | [195](/filings/0001628280-25-022764.md) | [194](/filings/0001290900-25-000010.md) | [172](/filings/0001628280-25-051174.md) | [163 d](/filings/0001628280-26-016520.md) | [170](/filings/0001628280-26-030679.md) | [172](/filings/0001628280-26-051962.md) | [152](/filings/0001628280-25-051174.md) | [155 d](/filings/0001628280-26-016520.md) | [171](/filings/0001628280-26-030679.md) | [195](/filings/0001628280-26-051962.md) |
| Cost of revenue | $m | [174](/filings/0001628280-24-045013.md) | [169 d](/filings/0001628280-26-016520.md) | [171](/filings/0001628280-25-022764.md) | [173](/filings/0001290900-25-000010.md) | [155](/filings/0001628280-25-051174.md) | [150 d](/filings/0001628280-26-016520.md) | [152](/filings/0001628280-26-030679.md) | [152](/filings/0001628280-26-051962.md) | [136](/filings/0001628280-25-051174.md) | [140 d](/filings/0001628280-26-016520.md) | [152](/filings/0001628280-26-030679.md) | [171](/filings/0001628280-26-051962.md) |
| Gross profit | $m | [29.3](/filings/0001628280-24-045013.md) | [24.4 d](/filings/0001628280-26-016520.md) | [23.2](/filings/0001628280-25-022764.md) | [20.5](/filings/0001290900-25-000010.md) | [16.4](/filings/0001628280-25-051174.md) | [13.1 d](/filings/0001628280-26-016520.md) | [17.8](/filings/0001628280-26-030679.md) | [19.5](/filings/0001628280-26-051962.md) | [16.0](/filings/0001628280-25-051174.md) | [15.0 d](/filings/0001628280-26-016520.md) | [19.8](/filings/0001628280-26-030679.md) | [24.7](/filings/0001628280-26-051962.md) |
| Selling, general and administrative | $m | [20.4](/filings/0001628280-24-045013.md) | [20.3 d](/filings/0001628280-26-016520.md) | [18.7](/filings/0001628280-25-022764.md) | [19.4](/filings/0001290900-25-000010.md) | [17.5](/filings/0001628280-25-051174.md) | [18.3 d](/filings/0001628280-26-016520.md) | [16.4](/filings/0001628280-26-030679.md) | [18.7](/filings/0001628280-26-051962.md) | [17.1](/filings/0001628280-25-051174.md) | [16.8 d](/filings/0001628280-26-016520.md) | [19.1](/filings/0001628280-26-030679.md) | [23.2](/filings/0001628280-26-051962.md) |
| Operating income | $m | [8.9](/filings/0001628280-24-045013.md) | [4.1 d](/filings/0001628280-26-016520.md) | [4.5](/filings/0001628280-25-022764.md) | [1.1](/filings/0001290900-25-000010.md) | [(1.1)](/filings/0001628280-25-051174.md) | [(5.3) d](/filings/0001628280-26-016520.md) | [1.4](/filings/0001628280-26-030679.md) | [0.8](/filings/0001628280-26-051962.md) | [(1.1)](/filings/0001628280-25-051174.md) | [(1.8) d](/filings/0001628280-26-016520.md) | [14.7](/filings/0001628280-26-030679.md) | [1.6](/filings/0001628280-26-051962.md) |
| Interest expense | $m | [2.6](/filings/0001628280-23-038031.md) | [2.4 d](/filings/0001628280-24-011213.md) | [2.3](/filings/0001628280-24-020727.md) | [2.4](/filings/0001290900-25-000010.md) | [2.4](/filings/0001628280-25-051174.md) | [2.2 d](/filings/0001628280-26-016520.md) | [2.5](/filings/0001628280-26-030679.md) | [2.3](/filings/0001628280-26-051962.md) | [4.1](/filings/0001628280-25-051174.md) | [4.2 d](/filings/0001628280-26-016520.md) | [4.1](/filings/0001628280-26-030679.md) | [2.9](/filings/0001628280-26-051962.md) |
| Income tax | $m | [1.4](/filings/0001628280-24-045013.md) | [(21.5) d](/filings/0001628280-26-016520.md) | [0.7](/filings/0001628280-25-022764.md) | [(0.3)](/filings/0001290900-25-000010.md) | [(1.5)](/filings/0001628280-25-051174.md) | [28.6 d](/filings/0001628280-26-016520.md) | [2.1](/filings/0001628280-26-030679.md) | [1.7](/filings/0001628280-26-051962.md) | [0.7](/filings/0001628280-25-051174.md) | [0.2 d](/filings/0001628280-26-016520.md) | [1.9](/filings/0001628280-26-030679.md) | [2.0](/filings/0001628280-26-051962.md) |
| Net income | $m | [7.3](/filings/0001628280-24-045013.md) | [23.3 d](/filings/0001628280-26-016520.md) | [2.9](/filings/0001628280-25-022764.md) | [(1.6)](/filings/0001290900-25-000010.md) | [9.5](/filings/0001628280-25-051174.md) | [(38.7) d](/filings/0001628280-26-016520.md) | [(4.3)](/filings/0001628280-26-030679.md) | [(4.8)](/filings/0001628280-26-051962.md) | [(7.1)](/filings/0001628280-25-051174.md) | [(6.6) d](/filings/0001628280-26-016520.md) | [0.9](/filings/0001628280-26-030679.md) | [(10.2)](/filings/0001628280-26-051962.md) |
| Diluted EPS | $ per share | [0.22](/filings/0001628280-23-038031.md) | not reported | [0.09](/filings/0001628280-24-020727.md) | [(0.05)](/filings/0001628280-24-034779.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.22](/filings/0001628280-23-038031.md) | not reported | [0.09](/filings/0001628280-24-020727.md) | [(0.05)](/filings/0001628280-24-034779.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [46.3](/filings/0001628280-23-038031.md) | [37.8](/filings/0001628280-25-012913.md) | [46.8](/filings/0001628280-24-020727.md) | [39.3](/filings/0001628280-24-034779.md) | [30.9](/filings/0001628280-24-045013.md) | [26.6](/filings/0001628280-26-016520.md) | [20.2](/filings/0001628280-25-022764.md) | [45.3](/filings/0001290900-25-000010.md) | [31.3](/filings/0001628280-25-051174.md) | [33.3](/filings/0001628280-26-051962.md) | [28.7](/filings/0001628280-26-030679.md) | [36.0](/filings/0001628280-26-051962.md) |
| Current assets | $m | [364](/filings/0001628280-23-038031.md) | [328](/filings/0001628280-25-012913.md) | [356](/filings/0001628280-24-020727.md) | [346](/filings/0001628280-24-034779.md) | [346](/filings/0001628280-24-045013.md) | [303](/filings/0001628280-26-016520.md) | [293](/filings/0001628280-25-022764.md) | [303](/filings/0001290900-25-000010.md) | [276](/filings/0001628280-25-051174.md) | [263](/filings/0001628280-26-051962.md) | [277](/filings/0001628280-26-030679.md) | [315](/filings/0001628280-26-051962.md) |
| Total assets | $m | [496](/filings/0001628280-23-038031.md) | [483](/filings/0001628280-25-012913.md) | [509](/filings/0001628280-24-020727.md) | [503](/filings/0001628280-24-034779.md) | [495](/filings/0001628280-24-045013.md) | [425](/filings/0001628280-26-016520.md) | [420](/filings/0001628280-25-022764.md) | [430](/filings/0001290900-25-000010.md) | [400](/filings/0001628280-25-051174.md) | [392](/filings/0001628280-26-051962.md) | [413](/filings/0001628280-26-030679.md) | [455](/filings/0001628280-26-051962.md) |
| Current liabilities | $m | [176](/filings/0001628280-23-038031.md) | [145](/filings/0001628280-25-012913.md) | [155](/filings/0001628280-24-020727.md) | [168](/filings/0001628280-24-034779.md) | [150](/filings/0001628280-24-045013.md) | [126](/filings/0001628280-26-016520.md) | [139](/filings/0001628280-25-022764.md) | [126](/filings/0001290900-25-000010.md) | [112](/filings/0001628280-25-051174.md) | [108](/filings/0001628280-26-051962.md) | [130](/filings/0001628280-26-030679.md) | [159](/filings/0001628280-26-051962.md) |
| Total liabilities | $m | [349](/filings/0001628280-23-038031.md) | [310](/filings/0001628280-25-012913.md) | [334](/filings/0001628280-24-020727.md) | [334](/filings/0001628280-24-034779.md) | [316](/filings/0001628280-24-045013.md) | [289](/filings/0001628280-26-016520.md) | [283](/filings/0001628280-25-022764.md) | [287](/filings/0001290900-25-000010.md) | [264](/filings/0001628280-25-051174.md) | [258](/filings/0001628280-26-051962.md) | [282](/filings/0001628280-26-030679.md) | [318](/filings/0001628280-26-051962.md) |
| Long-term debt | $m | [136](/filings/0001628280-23-038031.md) | [126](/filings/0001628280-25-012913.md) | [139](/filings/0001628280-24-020727.md) | [124](/filings/0001628280-24-034779.md) | [126](/filings/0001628280-24-045013.md) | [127](/filings/0001628280-26-016520.md) | [103](/filings/0001628280-25-022764.md) | [117](/filings/0001290900-25-000010.md) | [107](/filings/0001628280-25-051174.md) | [104](/filings/0001628280-26-051962.md) | [89.7](/filings/0001628280-26-030679.md) | [86.9](/filings/0001628280-26-051962.md) |
| Current portion of debt | $m | [18.3](/filings/0001628280-23-038031.md) | [15.3](/filings/0001628280-25-012913.md) | [16.4](/filings/0001628280-24-020727.md) | [17.5](/filings/0001628280-24-034779.md) | [3.0](/filings/0001628280-24-045013.md) | [8.4](/filings/0001628280-26-016520.md) | [13.9](/filings/0001628280-25-022764.md) | [0.9](/filings/0001290900-25-000010.md) | [0.9](/filings/0001628280-25-051174.md) | [0.9](/filings/0001628280-26-051962.md) | [0.9](/filings/0001628280-26-030679.md) | [1.9](/filings/0001628280-26-051962.md) |
| Shareholders' equity | $m | [147](/filings/0001628280-24-045013.md) | [173](/filings/0001628280-26-016520.md) | [176](/filings/0001628280-25-051174.md) | [170](/filings/0001628280-25-051174.md) | [179](/filings/0001628280-25-051174.md) | [136](/filings/0001628280-26-051962.md) | [137](/filings/0001628280-26-051962.md) | [143](/filings/0001628280-26-051962.md) | [137](/filings/0001628280-25-051174.md) | [133](/filings/0001628280-26-051962.md) | [131](/filings/0001628280-26-051962.md) | [136](/filings/0001628280-26-051962.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.5 d](/filings/0001628280-24-045013.md) | [8.3 d](/filings/0001628280-26-016520.md) | [(2.4)](/filings/0001628280-25-022764.md) | [12.6 d](/filings/0001290900-25-000010.md) | [(17.1) d](/filings/0001628280-25-051174.md) | [(26.6) d](/filings/0001628280-26-016520.md) | [15.2](/filings/0001628280-26-030679.md) | [18.9 d](/filings/0001628280-26-051962.md) | [(1.7) d](/filings/0001628280-25-051174.md) | [12.3 d](/filings/0001628280-26-016520.md) | [(1.6)](/filings/0001628280-26-030679.md) | [1.7 d](/filings/0001628280-26-051962.md) |
| Capital expenditure | $m | [6.0 d](/filings/0001628280-24-045013.md) | [4.5 d](/filings/0001628280-26-016520.md) | [5.1](/filings/0001628280-25-022764.md) | [6.2 d](/filings/0001290900-25-000010.md) | [3.3 d](/filings/0001628280-25-051174.md) | [4.0 d](/filings/0001628280-26-016520.md) | [3.8](/filings/0001628280-26-030679.md) | [1.5 d](/filings/0001628280-26-051962.md) | [1.8 d](/filings/0001628280-25-051174.md) | [3.6 d](/filings/0001628280-26-016520.md) | [2.7](/filings/0001628280-26-030679.md) | [3.1 d](/filings/0001628280-26-051962.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.9](/filings/0001628280-23-038031.md) | [33.2](/filings/0001628280-24-020727.md) | [33.4](/filings/0001628280-24-034779.md) | [33.4](/filings/0001628280-24-045013.md) | [33.4](/filings/0001628280-25-022764.md) | [33.4](/filings/0001290900-25-000010.md) | [33.5](/filings/0001628280-25-051174.md) | [33.7](/filings/0001628280-26-030679.md) | [33.8](/filings/0001628280-26-051962.md) | [33.9](/filings/0001628280-25-051174.md) | [35.5](/filings/0001628280-26-030679.md) | [34.8](/filings/0001628280-26-051962.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,632,682 at 2026-08-03, from the cover of the [10-Q filed 2026-08-03](/filings/0001628280-26-051962.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.